William Sandborn, MD — Chair Professor of Medicine Mayo Clinic College of Medicine Rochester, Minnesota Faculty Disclosure
	Lin Chang, MD Co-Director, Center for Neurovisceral Sciences and Women’s Health Associate Professor of Medicine David Geffen School of Medicine at UCLA Los Angeles, California Faculty Disclosure
	Maria T. Abreu, MD Director of Basic and Translational Research for the Inflammatory Bowel Disease Center Cedars-Sinai Medical Center Assistant Professor of Medicine University of California at Los Angeles School of Medicine Los Angeles, California Faculty Disclosure
	Ernest Seidman, MD Chief, Division of Gastroenterology Hôpital Sainte-Justine Montreal, Quebec Faculty Disclosure

FACULTY DISCLOSURES
It is the policy of The FCG Institute for Continuing Education to ensure independence, balance, objectivity, and scientific rigor and integrity in all its CME activities. Faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this activity. Disclosure information is for participant information. It is not assumed that these relationships will have a negative impact on the presentations.

Unlabeled or Investigational Use Statement Faculty of this CME activity may include discussions of products or devices that are not currently labeled for use by the US Food and Drug Administration (FDA). The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any use not approved by the FDA) of products and devices. The FCG Institute for Continuing Education, the faculty, and Forest Pharmaceuticals, Inc. do not endorse the use of any product outside the FDA-labeled indications. Health care professionals should not utilize the procedures, products, or diagnostic techniques discussed during this activity without the evaluation of their patient for contraindications or dangers of use.